OpenAlex
PricingAboutJobs
Log inGet started
Work

Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus

HTML

Year: 2006
Type: article
Source: Expert Review of Endocrinology & Metabolism
DOI: 10.1586/17446651.1.3.329
Authors: Curtis Triplitt, Ralph A DeFronzo
Institution: The University of Texas at San Antonio Health Science Center
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, incretin mimetics, type 2 diabetes, glucagon-like peptide-1, glucose-dependent insulin secretion, glucagon suppression, gastric emptying, hypophagia, weight loss, glycemic control, hypoglycemia, gastrointestinal adverse effects
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2141514017
FWCI: 0.664
Cites: 99
Cited by: 27
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security